An estimated 8,600 Canadians were diagnosed with uterine cancer in 2024. Endometrial cancer, which begins in the lining of the uterus, is the most common form of uterine cancer, making up about 95% of all diagnoses.
Over the past 30 years, rates of uterine cancers, including endometrial cancer, have been steadily increasing in Canada. While the majority of people diagnosed are over 50 years old and post-menopausal, endometrial cancer can affect people of any age whether or not they have reached menopause.
The concerning rise of cases over the last few decades makes endometrial cancer a pressing health issue in Canada.
Our research strategy
Given these challenges, the Terry Fox Research Institute has embarked on a multi-pronged strategy to fund the best endometrial cancer scientific teams and programs in the country.
In 2024/2025, roughly 4 per cent of the money invested by TFRI Research Grants Programs supported endometrial cancer research. This added up to a total investment of $770,000.*
To allocate its resources, TFRI has international experts evaluate the excellence and the potential for impact of all its research projects. This approach distinguishes our research investment strategy from all others in Canada and allows donors to be confident that their investment is supporting the best research in Canada.
*Our scientific discovery projects are interdisciplinary by design and often focus on more than one cancer type. The figures listed above are an estimate and should not be taken as exact figures.